AI ScreeningAI ChatPricing
  1. JP-listed companies
  2. Momotaro-Gene Inc.
  3. Financials
  4. Operating expenses

Momotaro-Gene Inc.【JP:E33052】

Market cap
P/E ratio
SummaryFinancialsDividendsHistoryWorkforce
Period EndOperating expenses (Million JPY)YoY (%)
Mar 31, 2023239-6.06%
Mar 31, 2022254-32.03%
Mar 31, 2021374+25.19%
Mar 31, 2020299-25.34%
Mar 31, 2019400+19.39%
Mar 31, 2018335+79.85%
Mar 31, 2017186+39.88%
Mar 31, 2016133+11.10%
Mar 31, 2015120-25.46%
Mar 31, 2014161+29.22%
Mar 31, 2013125+98.96%
Mar 31, 201263-59.66%
Mar 31, 2011155-9.74%
Mar 31, 2010172+74.20%
Mar 31, 200999

Income Statement

RevenueRevenue growth (%)Cost of revenueGross profitGross margin (%)Research & developmentSelling, general & administrativeOperating margin (%)Operating expenses Operating income Income before tax Pretax margin (%)Provision for income taxesEffective tax rate (%)Net income Net income margin (%)Earnings per shareDiluted EPSAdjusted EPSDividend payout ratio (%)Dividend per shareEBITDAEBITDA margin (%)

Balance Sheet

Cash and cash equivalents Marketable securities, current Total cash & short-term investmentsAccounts receivable, netInventoriesTotal current assetsProperty, plant and equipment, netMarketable securities, non-current Total non-current assetsTotal assets Accounts payableShort-term debtLong-term debt, current Total current liabilitiesLong-term debt, non-current Total non-current liabilitiesTotal liabilities Common stock and paid-in capital Retained earningsStockholders' equityTotal debtNet debtD/E ratio (%)Working capital

Cash Flow

Depreciation & amortizationStock-based compensationCash from operations Capital expendituresCash from investing Payments for dividends Repurchases of common stockProceeds from issuance of term debt, netRepayments of term debtCash from financing Free cash flowFCF margin (%)